Paul Gigot interviews Johns Hopkins specialist Marty Makary.
Up until last week, even prior Big Pharma naysayers were touting the successful development of effective COVID-19 vaccines. Within 15 months of the pandemic, not one, but three pharmaceutical companies developed and made available vaccines to lead the United States toward immunity nirvana. Now, over 250 million doses have been delivered in under five months.
Rather than congratulating Big Pharma on their tremendous efforts during a time of peril, last week President Biden held true on a controversial campaign promise doing the opposite.
Following increased scrutiny from progressive activists, the Biden administration announced its support of a plan rescinding intellectual property rights on COVID-19 vaccines, saying, The administration believes strongly in intellectual property protections, but in service of ending this pandemic, supports the waiver of those protections for COVID-19 vaccines.
«Lever les brevets des vaccins contre la Covid serait contre-productif» lopinion.fr - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lopinion.fr Daily Mail and Mail on Sunday newspapers.
Hartford Healthcare is gearing up to resume giving out the Johnson & Johnson COVID-19 vaccine. “We’re excited to be able to get back to doing that,” said Dr. James Cardon, Hartford Healthcare Executive Vice President. Recently the CDC and FDA announced a nationwide hold was lifted after 11 days. That came amid reports of rare but severe blood clots in…
(Credit: Getty Images)
As of Monday, 50% of the adult population in the United States had received at least one dose of COVID-19 vaccine, and 33% were fully vaccinated. In another metric milestone, more than 80% of seniors have had at least one shot, and nearly two thirds are fully jabbed.
Now that the (adult) glass is half full, how do we fill it? Four months into the campaign, the initial surge of vaccinations still has momentum, as we’ve averaged more than 3 million shots a day in early April. In pockets of America here and there, however, unused doses are evidence of flattening demand.